Japan's May factory activity contracts for 11th month, PMI shows
TOKYO, - Japan's manufacturing activity extended declines for nearly a year in May, as factories continued to take a hit from U.S. tariffs on Japanese goods, a business survey showed on Thursday.
While service-sector activity showed some resilience and stayed in expansionary territory, feeble manufacturing performance drove overall Japanese businesses back to contraction.
Japan's trade envoy is set to have a third round of talks with U.S. officials this week, but it was unclear if there would be a deal to lower the tariffs set by President Donald Trump, which threaten the auto sector and other key industries.
The au Jibun Bank flash Japan manufacturing purchasing managers' index edged up to 49.0 in May from April's final reading 48.7, but stayed below the 50.0 threshold that separates growth from contraction for the 11th month.
Factory output fell at a quicker pace than in April, while the decreases in new orders and new export business were slower than the previous month.
Cost pressures remained high but showed signs of easing. Input costs for factories rose at the slowest rate in 14 months, while output price inflation was down to the lowest in nearly four years.
Business confidence among manufacturers improved slightly in May after slipping to the weakest level in nearly five years in April. Meanwhile, service-sector managers' sentiment hit the lowest since January 2021 during the COVID-19 pandemic.
"Uncertainty around the future trade environment and foreign demand" appear to cloud Japanese businesses' outlook and output projections, said Annabel Fiddes, Economics Associate Director at S&P Global Market Intelligence, which compiled the survey.
The au Jibun Bank flash services PMI was down to 50.8 in May from 52.4 in April, with slower increases in new business, export business and employment.
Given the deterioration in both manufacturing and non-manufacturing activities, the au Jibun Bank flash Japan composite PMI fell to 49.8 in May from 51.2 in April.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
an hour ago
- Hindustan Times
India seeks exemption from US' 10% baseline tariff
The fate of the 10% baseline tariffs that the Trump administration invoked on imports from all countries on April 2 is among the issues now at the heart of negotiations between New Delhi and Washington as they attempt to hammer out an early tranche of the trade deal, people aware of the matter have said. Delhi is not in favour of replicating, as suggested by the American negotiators, the approach in the trade deal struck between the US and the UK, where British goods are still subject to the baseline tariffs, these people added. According to a person with direct knowledge of the discussions, Indian negotiators are pushing for their American counterparts to remove the baseline 10% rate as well as commit to assurances that the additional 16%, due to be implemented on July 9, will be left off. An American negotiating team led by assistant US Trade Representative Brendan Lynch 4 landed in Delhi on June for what is the fifth time negotiators from either side have gone to the other's capital for face-to-face talks. The American delegation is expected to be in Delhi till June 10, longer than the previously expected two-day visit. ALSO READ | India-US trade negotiations hit top gear, American delegation extends Delhi stay 'Ideally, both the 10% baseline tariff on Indian goods and the additional 16% from July 9 must end simultaneously after an interim deal is signed. Else, India will also have rights to continue proportionately similar tariffs on American goods till the time the US withdraws the entire 26% reciprocal tariff,' one of them said, citing a joint statement by the two countries' leaders issued on February 13 in Washington. While expounding 'Mission-500' to double bilateral trade to $500 billion by 2030 on February 13, the two leaders – Prime Minister Narendra Modi and President Donald Trump – in their joint statement mentioned the need for new 'fair-trade terms' that are 'mutually beneficial', the person said. A second person aware of the matter corroborated India's stance: 'Only a mutually beneficial deal would have a long life'. 'Both India and the US are sovereigns. One is the oldest democracy and the other is the largest democracy. While the US is the largest economy, India is the fastest growing major economy of the world. Hence, the deal must be balanced, equitable, fair and acceptable to their people,' the first person said. The second person added that India sees trade interests between both nations as being 'complementary and not competitive', hence New Delhi is open to giving greater market access to the American goods in the Indian market provided Washington reciprocates. 'The trade negotiations continue in New Delhi covering all these matters in a constructive manner as we speak and both sides are hopeful for a win-win,' he said. ALSO READ | Donald Trump claims India willing to cut 100% tariffs on US goods, 'but…' After UK industries faced American tariffs of 25% on all aluminium, steel and derivatives (announced on March 12), 25% tariff on passenger vehicles (announced on April 3), 25% tariff on automobile parts (beginning May 3), and a 10% baseline tariff on all imports (from April 5) – the UK and the US on May 8 announced an economic prosperity deal (EPD). The mini deal secured some concessions for the UK, but the 10% baseline tariff continued. Both partners are racing to conclude an interim, or regarded as an 'early harvest', deal before July 9, which will be followed by a wider first tranche of Bilateral Trade Agreement (BTA) by September-October 2025. After that a comprehensive BTA will be negotiated, they said. ALSO READ | How Donald Trump decided the tariff for India The current negotiations for an early harvest deal involve greater market access for goods by eliminating tariffs and non-tariff trade barriers, and improving supply chain integration, they said. The current New Delhi round is followed by a face-to-face negotiation between the two teams in the US. During that period, Union commerce and industry minister Piyush Goyal was also in the US from May 17-22 where he held meetings with his counterparts, US commerce secretary Howard Lutnick and USTR Jamieson Greer.
Time of India
3 hours ago
- Time of India
Trump-Musk Break Up Drama Gets UGLIER: Trump Warns Of ‘Severe Consequences
/ Jun 08, 2025, 02:47AM IST U.S. President Donald Trump has issued a sharp warning to Elon Musk over alleged political funding. In a recent interview, Trump said Musk would face 'very serious consequences' if he backs Democrats. The remarks follow a series of public jabs between the two, including accusations and social media posts. Watch.
Time of India
5 hours ago
- Time of India
Ayurvedic & herbal products manufacturers in Indore ramp up production as Covid cases increase
Indore: As Covid-19 cases are witnessing an uptick, manufacturers of Ayurvedic and herbal products in Indore have ramped up their production capacities, anticipating a surge in demand for immunity-boosting products. Usually, summers remain the lean season for immunity booster syrups and tablets, but the resurgence of Covid-19 cases led to a jump in enquiries, prompting many units to prepare for increased production ahead of their usual season. Ayush Nirmata Sangh secretary Ashish Dubey said, "We are anticipating a surge in demand for immunity boosters as cases of Covid-19 again started to increase. Many units started preparations and are gradually increasing production." Another manufacturer owner of a local Ayurvedic firm Ravi Kumar said, "We saw an increase in enquiries for our immunity products. To meet this demand, we are expanding our operations to ensure we can deliver quality products to our customers promptly. Also, monsoon and winters are main demand period of Ayurvedic products when demand rises." Industry insiders noted that if the consumption of these products would not meet their expectations, they would still find a market during the monsoon and winter seasons when the demand for syrups and immunity boosters typically spikes. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch CFD với công nghệ và tốc độ tốt hơn IC Markets Đăng ký Undo Ayurvedic products produced in Indore are distributed across various states in India, including Delhi, Punjab, Maharashtra, Uttar Pradesh, and Uttarakhand, according to local manufacturers. In response to the heightened demand, many manufacturing units are transitioning to automatic production processes, while others are opting for semi-automatic configurations to enhance efficiency. Indore is home to around 240 Ayurvedic medicine manufacturing units, with the total market size exceeding an impressive Rs 1000 crore, as reported by Ayush Nirmata Sangh.
